On August16th, www.glinfo.com reported that on August 15th, 2024, Zhejiang Jingxin Pharmaceutical (002020.SZ) stated during a specific object investigation that clinical trials of JX11502MA capsules and KefuXin enteric-coated capsules II are underway; JX2105 capsules have received clinical trial approvals, and Phase I clinical trials are progressing smoothly; more than 10 other research projects are being carried out in an orderly manner.
京新药业(002020.SZ)：JX11502MA胶囊和康复新肠溶胶囊II临床进行中
Zhejiang Jingxin Pharmaceutical (002020.SZ): JX11502MA capsules and Kangfu Xin enteric capsules II clinical trials are underway.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.